Patenting adverse event information: A commentary from the patent law
‘Enhanced funding of pharmacoepidemiology through patenting the disclosure of adverse event information, ’ John Classen, patentability, novel, nonobvious
Pharmacoepidemiology & Drug Safety
Wagner, R. Polk, "Patenting adverse event information: A commentary
from the patent law" (2006). Faculty Scholarship at Penn Carey Law. 2646.
15 Pharmacoepidemiology & Drug Safety 396 (2006).